Single-dose patients faced fewer side effects and clinic visits with no loss in outcomes
The drug works alongside a reduced-calorie diet and added physical activity
CPBI Forum panelists outline how to rethink diabetes sick day management
Economic model projects multi-billion-dollar gains across five countries
Updated agreement reinforces staged pricing cuts for new generic drugs
Most patients relapse within five years, and Bausch Health’s PrOKEDI targets that risk
